article banner

China’s Fosun bids to buy India’s Gland Pharma

rich text with image

“The pharma, healthcare and biotech sector has seen high levels of activity in the M&A space during 2015. The transaction volumes have been the highest in the last five years. In 2015, 65 M&A transactions valued at $4.04 billion were executed as against 64 transactions valued at $5.7 billion in 2014,” according to advisory Grant Thornton’s Annual Deal Tracker in 2015.

This article appeared in Live Mint on 17th May, 2016